Relmada Therapeutics, Inc. (RLMD)
NASDAQ: RLMD · Real-Time Price · USD
3.610
-0.600 (-14.25%)
Nov 16, 2026, 4:00 PM EST - Market closed
Relmada Therapeutics Market Cap
Relmada Therapeutics has a market cap or net worth of $385.17 million as of November 16, 2026. It is the 16,040th most valuable company in the world and the 2,895th biggest in the United States. Its market cap has increased by 32.95% in one year.
Market Cap
385.17M
Enterprise Value
183.05M
1-Year Change
32.95%
Global Rank
Country Rank
#2,895 United States
Category
ChartMarket Cap Chart
Since September 30, 2015, Relmada Therapeutics's market cap has increased from $56.60M to $385.17M, an increase of 580.51%. That is a compound annual growth rate of 18.79%.
| Date | Market Cap | % Change |
|---|---|---|
| Nov 16, 2026 | 385.17M | 8.74% |
| Dec 31, 2025 | 354.20M | 2,156.05% |
| Dec 31, 2024 | 15.70M | -87.40% |
| Dec 29, 2023 | 124.60M | 18.67% |
| Dec 30, 2022 | 105.00M | -73.42% |
| Dec 31, 2021 | 395.00M | -24.17% |
| Dec 31, 2020 | 520.90M | 30.00% |
| Dec 31, 2019 | 400.70M | 1,125.38% |
| Dec 31, 2018 | 32.70M | 247.87% |
| Dec 29, 2017 | 9.40M | -28.24% |
| Dec 30, 2016 | 13.10M | -54.67% |
| Dec 31, 2015 | 28.90M | -48.94% |
| Sep 30, 2015 | 56.60M | - |
View and export this data all the way back to 2015. Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Ovid Therapeutics | 479.38M |
| DiaMedica Therapeutics | 474.29M |
| Shattuck Labs | 473.57M |
| Gyre Therapeutics | 471.74M |
| Oculis Holding AG | 471.63M |
| MiMedx Group | 468.42M |
| Avalo Therapeutics | 448.71M |
| Arvinas | 446.61M |